Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
107.04
-0.26 (-0.24%)
Dec 26, 2024, 2:19 PM EST - Market open
Zimmer Biomet Holdings Revenue
Zimmer Biomet Holdings had revenue of $1.82B in the quarter ending September 30, 2024, with 4.03% growth. This brings the company's revenue in the last twelve months to $7.60B, up 4.35% year-over-year. In the year 2023, Zimmer Biomet Holdings had annual revenue of $7.39B with 6.55% growth.
Revenue (ttm)
$7.60B
Revenue Growth
+4.35%
P/S Ratio
2.90
Revenue / Employee
$421,972
Employees
18,000
Market Cap
21.31B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.39B | 454.30M | 6.55% |
Dec 31, 2022 | 6.94B | 112.60M | 1.65% |
Dec 31, 2021 | 6.83B | 699.80M | 11.42% |
Dec 31, 2020 | 6.13B | -1.85B | -23.24% |
Dec 31, 2019 | 7.98B | 49.30M | 0.62% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Koninklijke Philips | 20.12B |
Labcorp Holdings | 12.71B |
Biogen | 9.61B |
STERIS | 5.33B |
Illumina | 4.39B |
The Cooper Companies | 3.90B |
BeiGene | 3.35B |
Waters | 2.91B |
ZBH News
- 6 days ago - Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 8 days ago - Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024 - PRNewsWire
- 13 days ago - Zimmer Biomet Receives FDA Clearance for OsseoFit™ Stemless Shoulder System for Total Shoulder Replacement - PRNewsWire
- 22 days ago - Zimmer Biomet Receives FDA Clearance for Persona® SoluTion™ PPS® Femur - PRNewsWire
- 4 weeks ago - Zimmer Biomet Receives FDA Approval for Oxford® Cementless Partial Knee, Only Cementless Partial Knee Replacement Implant in the U.S. - PRNewsWire
- 5 weeks ago - Zimmer Biomet to Present at Citi's 2024 Global Healthcare Conference - PRNewsWire
- 5 weeks ago - Zimmer Biomet Announces CE Mark Certification for Persona® Revision Knee System - PRNewsWire
- 6 weeks ago - Zimmer Biomet Welcomes Arnold Schwarzenegger as Chief Movement Officer - PRNewsWire